Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18209
Country/Region: Kenya
Year: 2016
Main Partner: Liverpool VCT, Care and Treatment
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $3,319,939 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $173,013
Care: TB/HIV (HVTB) $45,157
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $34,164
Sexual Prevention: Abstinence/Be Faithful (HVAB) $152,487
Testing: HIV Testing and Counseling (HVCT) $702,452
Sexual Prevention: Other Sexual Prevention (HVOP) $1,440,352
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $484,097
Treatment: Adult Treatment (HTXS) $288,217
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 1,814
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 4,104
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 1,759
GEND_GBV Number of people receiving post-GBV care 2017 5,863
HTS_TST Age/sex: <1 2017 50
HTS_TST Age/sex: 1-9 2017 11,489
HTS_TST Age/sex: 10-14 Female 2017 1,664
HTS_TST Age/sex: 10-14 Male 2017 2,220
HTS_TST Age/sex: 15-19 Female 2017 3,080
HTS_TST Age/sex: 15-19 Male 2017 3,977
HTS_TST Age/sex: 20-24 Female 2017 9,617
HTS_TST Age/sex: 20-24 Male 2017 11,739
HTS_TST Age/sex: 25-49 Female 2017 24,816
HTS_TST Age/sex: 25-49 Male 2017 28,451
HTS_TST Age/sex: 50+ Female 2017 3,120
HTS_TST Age/sex: 50+ Male 2017 4,115
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 8,215
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 5,264
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 53,277
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 19,299
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 107,373
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,193
HTS_TST Service Delivery Point (Facility): Inpatient 2017 4,913
HTS_TST Service Delivery Point (Facility): Malnutrition facilities 2017 1
HTS_TST Service Delivery Point (Facility): Other PITC 2017 648
HTS_TST Service Delivery Point (Facility): Outpatient 2017 51,353
HTS_TST Service Delivery Point (Facility): Pediatric 2017 848
HTS_TST Service Delivery Point (Facility): PMTCT 2017 4,913
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 185
HTS_TST Service Delivery Point (Facility): VCT 2017 21,185
HTS_TST Service Delivery Point (Facility): VMMC 2017 1,681
HTS_TST Sum of Age/Sex disaggregates 2017 92,799
HTS_TST Sum of Aggregated Age/Sex <15 2017 13,479
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 72,576
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 86,055
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 32
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 23
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 84
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 24
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 291
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 68
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 1,250
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 340
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 250
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 67
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 124
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 133
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 76
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 2,204
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 558
KP_MAT Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months 2017 2,937
KP_MAT Sex: Female 2017 457
KP_MAT Sex: Male 2017 2,780
KP_MAT Sum of Sex disaggregates 2017 3,237
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 52,540
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 2,016
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 4,641
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 10,790
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 69,986
KP_PREV Total estimated number of key population in the catchment area 2017 66,244
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 50,237
KP_PREV_den By key population type: Females who inject drugs (Female PWID) (Denominator: Total estimated number of key population in the catchment area) 2017 3,795
KP_PREV_den By key population type: Males who inject drugs (Male PWID) (Denominator: Total estimated number of key population in the catchment area) 2017 1,423
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 10,178
KP_PREV_den By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 612
OVC_SERV Age/Sex: 18+ Female 2017 11,408
OVC_SERV Age/Sex: 18+ Male 2017 183
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 7,449
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 2,571
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 22,711
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female <1 2017 20
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 1-9 2017 1,115
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 10-14 2017 1,346
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 15-17 2017 1,107
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2017 1,077
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 25+ 2017 3,049
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male <1 2017 23
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 1-9 2017 1,070
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 10-14 2017 1,377
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 15-17 2017 1,013
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 18-24 2017 505
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support 1-9 Male 2017 1,072
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female <1 2017 22
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 1-9 2017 1,071
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2017 1,765
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2017 4,594
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 18-24 2017 767
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male <1 2017 23
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 10-14 2017 947
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 15-17 2017 468
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 18-24 2017 175
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female <1 2017 166
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 1-9 2017 1,369
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 10-14 2017 2,728
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 15-17 2017 2,361
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2017 1,268
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male <1 2017 23
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 1-9 2017 1,073
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 10-14 2017 2,219
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 15-17 2017 1,731
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 18-24 2017 1,450
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 25+ 2017 1,272
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female <1 2017 281
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 1-9 2017 1,043
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 10-14 2017 4,287
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 15-17 2017 534
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 18-24 2017 151
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male <1 2017 23
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 1-9 2017 1,072
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 10-14 2017 947
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 15-17 2017 462
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 18-24 2017 177
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female <1 2017 93
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2017 1,167
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2017 1,325
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2017 971
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male <1 2017 22
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 10-14 2017 947
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 15-17 2017 467
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 18-24 2017 176
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Programs Female 1-9 2017 1,260
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Programs Male 1-9 2017 1,079
OVC_SERV Sum of Age/Sex disaggregates 2017 11,591
PMTCT_ART Already on ART at beginning of current pregnancy 2017 25
PMTCT_ART New on ART 2017 9
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 880
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 2
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 23
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 1
PMTCT_EID Sum of Infant Age disaggregates 2017 25
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 8
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 41
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 265
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 566
PMTCT_STAT By: Known positives at entry 2017 35
PMTCT_STAT By: Number of new positives identified 2017 13
PMTCT_STAT Number of new ANC and L&D clients 2017 880
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 880
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 1
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 4
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 25
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 5
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 1
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 9
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 2
PMTCT_STAT Sum of Positives Status disaggregates 2017 48
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 8
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 41
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 265
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 566
PP_PREV Aggregated Age/sex: <15 Female 2017 3,363
PP_PREV Aggregated Age/sex: <15 Male 2017 246
PP_PREV Aggregated Age/sex: 15+ Female 2017 8,443
PP_PREV Aggregated Age/sex: 15+ Male 2017 46
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 12,240
PP_PREV Total number of people in the target population 2017 12,292
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 17
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 22
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 39
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 39
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 706
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 706
TB_SCREENDX Screen Result: Screened Positive for TB 2017 784
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,349
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 543
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 14
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 9
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 3,915
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 22
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 28
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 53
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 53
TX_CURR Age/Sex: <1-9 2017 15
TX_CURR Age/Sex: 10-14 Female 2017 4
TX_CURR Age/Sex: 10-14 Male 2017 4
TX_CURR Age/Sex: 15-19 Female 2017 21
TX_CURR Age/Sex: 15-19 Male 2017 5
TX_CURR Age/Sex: 20-24 Female 2017 300
TX_CURR Age/Sex: 20-24 Male 2017 26
TX_CURR Age/Sex: 25-49 Female 2017 2,526
TX_CURR Age/Sex: 25-49 Male 2017 382
TX_CURR Age/Sex: 50+ Female 2017 502
TX_CURR Age/Sex: 50+ Male 2017 130
TX_CURR Aggregated Age/Sex: <15 Female 2017 14
TX_CURR Aggregated Age/Sex: <15 Male 2017 9
TX_CURR Aggregated Age/Sex: 15+ Female 2017 3,349
TX_CURR Aggregated Age/Sex: 15+ Male 2017 543
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 3,915
TX_CURR Sum of age/sex disaggregates 2017 26
TX_CURR Sum of Aggregated Age/Sex <15 2017 23
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 3,892
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 3,915
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 6
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 7
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,535
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 277
TX_NEW By Age/Sex: 1-9 2017 4
TX_NEW By Age/Sex: 10-14 Female 2017 4
TX_NEW By Age/Sex: 10-14 Male 2017 7
TX_NEW By Age/Sex: 15-19 Female 2017 29
TX_NEW By Age/Sex: 15-19 Male 2017 4
TX_NEW By Age/Sex: 20-24 Female 2017 137
TX_NEW By Age/Sex: 20-24 Male 2017 31
TX_NEW By Age/Sex: 25-49 Female 2017 1,208
TX_NEW By Age/Sex: 25-49 Male 2017 219
TX_NEW By Age/Sex: 50+ Female 2017 160
TX_NEW By Age/Sex: 50+ Male 2017 23
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,825
TX_NEW Sum of Age/Sex disaggregates 2017 1,822
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,825
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 3,513
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 3,529
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 26
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 8
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 3,005
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 490
TX_PVLS Numerator: Indication: Routine 2017 3,401
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 14
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 8
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 3,017
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 479
TX_PVLS_den Denominator: Indication: Routine 2017 2,145
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 27
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 120
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 27
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,081
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 165
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 143
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 21
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,411
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 249
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,632
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,825
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 77
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 28
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 133
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 31
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,170
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 215
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 175
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 23
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,535
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 277
Cross Cutting Budget Categories and Known Amounts Total: $4,352,688
Gender: Gender Based Violence (GBV) $218,177
Post GBV Care
Gender: Gender Equality $223,604
Equity in HIV prevention, care, treatment and support
Human Resources for Health $1,057,209
Key Populations: MSM and TG $392,942
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Conducting epidemiologic, social science, and operational research among MSM/TG and their sex partners
Monitoring and evaluation of MSM/TG programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for MSM/TG
Key Populations: Sex Workers $1,178,826
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Monitoring and evaluation of SW programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for SWs
Economic Strengthening $785,884
Education $103,104
Condoms: Policy, Tools, and Services $196,471
Condoms: Commodities $196,471